24 de julio del 2024
The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.
On July 9, 2024, Endo USA, Inc. recalled Clonazepam 0.125mg and 0.25mg Orally Disintegrating tablets (ODT) from a single lot due to a packaging error. Some cartons labeled as containing Clonazepam 0.125mg ODT may actually contain Clonazepam 0.25mg ODT. Clonazepam is a benzodiazepine used to treat panic disorder or certain types of seizures. Taking a higher dose than intended may lead to adverse effects such as drowsiness, confusion, slow muscle reactions, sleepiness and loss in muscle tone. For more information, see here.
Última actualización: 24 de julio del 2024